A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer: Everolimus and Bicalutamide for CRPC
Journal article published in 2016 by
Helen Chow,
Paramita M. Ghosh,
Ralph deVere White,
Christopher P. Evans,
Marc A. Dall'Era,
Stanley A. Yap,
Yueju Li,
Laurel A. Beckett,
Primo N. Lara,
Chong-Xian Pan
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
